PTP4A3 and colorectal cancer: We next transfected HCT116 cells with shRNA that we have previously found to be effective against PRL-351, producing a > 50% reduction in PRL-3 protein (Supplemental Fig. 5), and saw the expected decrease in colorectal cancer cell migration (Fig. 5c, Supplemental Fig. 9).